IBDEI1CR ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21857,0)
 ;;=J45.52^^70^931^30
 ;;^UTILITY(U,$J,358.3,21857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21857,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,21857,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,21857,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,21858,0)
 ;;=J45.50^^70^931^31
 ;;^UTILITY(U,$J,358.3,21858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21858,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,21858,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,21858,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,21859,0)
 ;;=J43.0^^70^931^32
 ;;^UTILITY(U,$J,358.3,21859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21859,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,21859,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,21859,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,21860,0)
 ;;=J45.901^^70^931^3
 ;;^UTILITY(U,$J,358.3,21860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21860,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,21860,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,21860,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,21861,0)
 ;;=J45.902^^70^931^4
 ;;^UTILITY(U,$J,358.3,21861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21861,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,21861,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,21861,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,21862,0)
 ;;=J45.909^^70^931^5
 ;;^UTILITY(U,$J,358.3,21862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21862,1,3,0)
 ;;=3^Asthma,Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,21862,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,21862,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,21863,0)
 ;;=J42.^^70^931^13
 ;;^UTILITY(U,$J,358.3,21863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21863,1,3,0)
 ;;=3^Chr Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,21863,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,21863,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,21864,0)
 ;;=I95.1^^70^932^1
 ;;^UTILITY(U,$J,358.3,21864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21864,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,21864,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,21864,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,21865,0)
 ;;=I73.9^^70^932^2
 ;;^UTILITY(U,$J,358.3,21865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21865,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,21865,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,21865,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,21866,0)
 ;;=I80.13^^70^932^3
 ;;^UTILITY(U,$J,358.3,21866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21866,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Femoral Vein
 ;;^UTILITY(U,$J,358.3,21866,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,21866,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,21867,0)
 ;;=I80.213^^70^932^4
 ;;^UTILITY(U,$J,358.3,21867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21867,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Iliac Vein
 ;;^UTILITY(U,$J,358.3,21867,1,4,0)
 ;;=4^I80.213
 ;;^UTILITY(U,$J,358.3,21867,2)
 ;;=^5007833
 ;;^UTILITY(U,$J,358.3,21868,0)
 ;;=I80.223^^70^932^7
 ;;^UTILITY(U,$J,358.3,21868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21868,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Popliteal Vein
 ;;^UTILITY(U,$J,358.3,21868,1,4,0)
 ;;=4^I80.223
 ;;^UTILITY(U,$J,358.3,21868,2)
 ;;=^5007837
 ;;^UTILITY(U,$J,358.3,21869,0)
 ;;=I80.233^^70^932^8
